 Jessica Rove
Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 7 | 2024 | 680 | 2.290 |
Why?
| | Cardiac Surgical Procedures | 5 | 2024 | 611 | 1.990 |
Why?
| | Tissue and Organ Procurement | 6 | 2024 | 343 | 1.420 |
Why?
| | Extracorporeal Membrane Oxygenation | 5 | 2023 | 390 | 1.050 |
Why?
| | Thoracic Surgery | 2 | 2024 | 143 | 0.740 |
Why?
| | Educational Personnel | 1 | 2022 | 11 | 0.740 |
Why?
| | Lidocaine | 1 | 2022 | 55 | 0.720 |
Why?
| | Gelatin | 1 | 2022 | 56 | 0.710 |
Why?
| | Surgeons | 2 | 2024 | 340 | 0.700 |
Why?
| | Mitral Valve Insufficiency | 1 | 2022 | 68 | 0.680 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 129 | 0.680 |
Why?
| | Vascular Grafting | 1 | 2020 | 15 | 0.650 |
Why?
| | Phospholipases A2, Secretory | 4 | 2019 | 14 | 0.610 |
Why?
| | General Surgery | 1 | 2022 | 206 | 0.600 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2022 | 198 | 0.590 |
Why?
| | Echocardiography | 1 | 2022 | 648 | 0.590 |
Why?
| | Perfusion | 5 | 2024 | 251 | 0.560 |
Why?
| | Esophageal Neoplasms | 3 | 2017 | 348 | 0.510 |
Why?
| | Stomach Diseases | 1 | 2017 | 20 | 0.510 |
Why?
| | Organ Preservation | 4 | 2024 | 125 | 0.480 |
Why?
| | Anastomosis, Surgical | 1 | 2017 | 164 | 0.480 |
Why?
| | Esophagectomy | 1 | 2017 | 135 | 0.460 |
Why?
| | Enzyme Inhibitors | 4 | 2013 | 821 | 0.440 |
Why?
| | Deglutition Disorders | 1 | 2017 | 154 | 0.440 |
Why?
| | Coronary Artery Disease | 2 | 2020 | 750 | 0.430 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 890 | 0.430 |
Why?
| | Cognition | 1 | 2023 | 1271 | 0.420 |
Why?
| | Reoperation | 1 | 2017 | 637 | 0.400 |
Why?
| | Internship and Residency | 2 | 2020 | 1269 | 0.390 |
Why?
| | Group II Phospholipases A2 | 2 | 2012 | 10 | 0.380 |
Why?
| | Humans | 43 | 2024 | 145785 | 0.360 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2191 | 0.350 |
Why?
| | Lung Neoplasms | 5 | 2019 | 2668 | 0.340 |
Why?
| | Quality of Life | 1 | 2023 | 3211 | 0.320 |
Why?
| | Retrospective Studies | 12 | 2024 | 17330 | 0.310 |
Why?
| | Bronchiectasis | 2 | 2012 | 115 | 0.310 |
Why?
| | Pneumonectomy | 2 | 2012 | 167 | 0.300 |
Why?
| | Heart | 2 | 2023 | 626 | 0.290 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 3 | 2012 | 1192 | 0.290 |
Why?
| | Postoperative Complications | 2 | 2017 | 2977 | 0.280 |
Why?
| | Tissue Donors | 4 | 2024 | 420 | 0.280 |
Why?
| | Apoptosis | 4 | 2013 | 2445 | 0.260 |
Why?
| | NF-kappa B | 5 | 2012 | 667 | 0.260 |
Why?
| | Mycobacterium Infections, Nontuberculous | 2 | 2012 | 339 | 0.250 |
Why?
| | Lung Transplantation | 2 | 2024 | 332 | 0.240 |
Why?
| | Osteogenesis | 2 | 2012 | 204 | 0.240 |
Why?
| | Brain Death | 2 | 2024 | 60 | 0.240 |
Why?
| | United States | 7 | 2024 | 16126 | 0.240 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2019 | 132 | 0.230 |
Why?
| | Thoracic Surgical Procedures | 2 | 2024 | 94 | 0.230 |
Why?
| | Consensus | 2 | 2024 | 479 | 0.220 |
Why?
| | Adult | 13 | 2024 | 40882 | 0.220 |
Why?
| | Aortic Valve Stenosis | 2 | 2012 | 256 | 0.220 |
Why?
| | Aortic Valve | 2 | 2012 | 364 | 0.220 |
Why?
| | Cell Proliferation | 3 | 2013 | 2514 | 0.220 |
Why?
| | Adenocarcinoma | 3 | 2013 | 926 | 0.210 |
Why?
| | Treatment Outcome | 7 | 2022 | 11794 | 0.200 |
Why?
| | RNA Interference | 2 | 2012 | 475 | 0.200 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 46 | 0.200 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 78 | 0.200 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 33 | 0.200 |
Why?
| | Physicians, Women | 1 | 2024 | 90 | 0.190 |
Why?
| | Time Factors | 6 | 2024 | 7134 | 0.190 |
Why?
| | Biglycan | 1 | 2012 | 3 | 0.190 |
Why?
| | Travel | 1 | 2023 | 136 | 0.180 |
Why?
| | Coronary Artery Bypass | 2 | 2024 | 268 | 0.180 |
Why?
| | American Heart Association | 1 | 2024 | 358 | 0.180 |
Why?
| | Hernia, Inguinal | 1 | 2012 | 43 | 0.180 |
Why?
| | Herniorrhaphy | 1 | 2012 | 76 | 0.180 |
Why?
| | Jugular Veins | 1 | 2012 | 42 | 0.170 |
Why?
| | Technology Transfer | 1 | 2021 | 9 | 0.170 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 334 | 0.170 |
Why?
| | Toll-Like Receptor 2 | 1 | 2012 | 125 | 0.170 |
Why?
| | ras Proteins | 1 | 2012 | 150 | 0.170 |
Why?
| | Spinal Cord Ischemia | 1 | 2022 | 60 | 0.170 |
Why?
| | Echocardiography, Transesophageal | 1 | 2022 | 132 | 0.170 |
Why?
| | Periodicals as Topic | 1 | 2024 | 209 | 0.170 |
Why?
| | Hypothermia, Induced | 1 | 2022 | 96 | 0.170 |
Why?
| | Mitral Valve | 1 | 2022 | 95 | 0.170 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 413 | 0.170 |
Why?
| | Death | 1 | 2022 | 132 | 0.170 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2012 | 48 | 0.170 |
Why?
| | Thoracotomy | 2 | 2017 | 88 | 0.170 |
Why?
| | Computed Tomography Angiography | 1 | 2022 | 146 | 0.170 |
Why?
| | Graft Survival | 1 | 2023 | 519 | 0.170 |
Why?
| | Bronchi | 1 | 2012 | 263 | 0.160 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2022 | 138 | 0.160 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2011 | 56 | 0.160 |
Why?
| | Calcinosis | 1 | 2012 | 234 | 0.160 |
Why?
| | Genetic Therapy | 1 | 2012 | 316 | 0.160 |
Why?
| | Coronary Circulation | 1 | 2020 | 134 | 0.160 |
Why?
| | Shock, Cardiogenic | 1 | 2020 | 65 | 0.150 |
Why?
| | Phosphorylation | 5 | 2013 | 1708 | 0.150 |
Why?
| | Blotting, Western | 5 | 2013 | 1184 | 0.150 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2022 | 248 | 0.150 |
Why?
| | Graft Rejection | 1 | 2023 | 521 | 0.150 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2022 | 228 | 0.150 |
Why?
| | Seizures | 1 | 2023 | 485 | 0.150 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2021 | 154 | 0.150 |
Why?
| | Blood Flow Velocity | 1 | 2020 | 421 | 0.150 |
Why?
| | Proto-Oncogene Proteins | 1 | 2012 | 625 | 0.140 |
Why?
| | Heart Arrest | 1 | 2022 | 411 | 0.140 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2013 | 136 | 0.140 |
Why?
| | Dinoprostone | 1 | 2019 | 180 | 0.140 |
Why?
| | Phylogeny | 1 | 2022 | 917 | 0.130 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 2 | 2013 | 172 | 0.130 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 327 | 0.130 |
Why?
| | Health Personnel | 1 | 2024 | 757 | 0.130 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2012 | 641 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1752 | 0.130 |
Why?
| | Mental Health | 1 | 2024 | 796 | 0.130 |
Why?
| | Cell Movement | 1 | 2012 | 963 | 0.130 |
Why?
| | Gastric Emptying | 1 | 2017 | 36 | 0.130 |
Why?
| | Antineoplastic Agents | 2 | 2012 | 2219 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2023 | 948 | 0.120 |
Why?
| | Laparotomy | 1 | 2017 | 113 | 0.120 |
Why?
| | Critical Illness | 1 | 2023 | 900 | 0.120 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 979 | 0.120 |
Why?
| | Cell Line, Tumor | 5 | 2012 | 3551 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 442 | 0.110 |
Why?
| | Anxiety | 1 | 2023 | 1122 | 0.110 |
Why?
| | Hospital Mortality | 1 | 2020 | 1038 | 0.110 |
Why?
| | Hydrogels | 1 | 2022 | 701 | 0.110 |
Why?
| | Aged | 8 | 2024 | 26217 | 0.100 |
Why?
| | Asphyxia | 1 | 2014 | 24 | 0.100 |
Why?
| | Heart Defects, Congenital | 1 | 2012 | 910 | 0.100 |
Why?
| | Registries | 1 | 2021 | 2410 | 0.090 |
Why?
| | Clinical Competence | 1 | 2020 | 1247 | 0.090 |
Why?
| | Thoracoscopy | 2 | 2012 | 60 | 0.090 |
Why?
| | Middle Aged | 8 | 2024 | 36309 | 0.090 |
Why?
| | Veterans | 1 | 2024 | 1642 | 0.090 |
Why?
| | Mutation | 1 | 2012 | 4090 | 0.080 |
Why?
| | Radiation Injuries | 1 | 2012 | 149 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2012 | 2028 | 0.080 |
Why?
| | Organ Transplantation | 2 | 2024 | 253 | 0.080 |
Why?
| | Male | 11 | 2024 | 73012 | 0.080 |
Why?
| | Transfection | 2 | 2012 | 927 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2012 | 2805 | 0.080 |
Why?
| | Aorta, Thoracic | 2 | 2022 | 288 | 0.080 |
Why?
| | Mice | 2 | 2022 | 18358 | 0.070 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2012 | 76 | 0.070 |
Why?
| | Alkaline Phosphatase | 2 | 2012 | 144 | 0.070 |
Why?
| | Female | 9 | 2024 | 79045 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6085 | 0.070 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 444 | 0.060 |
Why?
| | Patient Selection | 2 | 2012 | 739 | 0.060 |
Why?
| | Animals | 3 | 2022 | 38106 | 0.060 |
Why?
| | Databases, Factual | 2 | 2020 | 1491 | 0.060 |
Why?
| | Cell Survival | 2 | 2012 | 1105 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2021 | 8347 | 0.050 |
Why?
| | Raffinose | 1 | 2023 | 29 | 0.050 |
Why?
| | Allopurinol | 1 | 2023 | 70 | 0.050 |
Why?
| | Donor Selection | 1 | 2024 | 79 | 0.050 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 221 | 0.050 |
Why?
| | Shock | 1 | 2024 | 110 | 0.050 |
Why?
| | Cell Growth Processes | 1 | 2012 | 48 | 0.050 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 28 | 0.050 |
Why?
| | Surgical Mesh | 1 | 2012 | 50 | 0.050 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 118 | 0.050 |
Why?
| | Paraplegia | 1 | 2022 | 60 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2012 | 119 | 0.040 |
Why?
| | Adenosine | 1 | 2023 | 255 | 0.040 |
Why?
| | Workplace | 1 | 2024 | 272 | 0.040 |
Why?
| | Signal Transduction | 3 | 2013 | 5226 | 0.040 |
Why?
| | Glutathione | 1 | 2023 | 370 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 174 | 0.040 |
Why?
| | Airway Management | 1 | 2012 | 81 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 267 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 264 | 0.040 |
Why?
| | Blood Vessel Prosthesis | 1 | 2022 | 140 | 0.040 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 254 | 0.040 |
Why?
| | Tumor Burden | 1 | 2012 | 325 | 0.040 |
Why?
| | Occupational Health | 1 | 2024 | 213 | 0.040 |
Why?
| | Secondary Prevention | 1 | 2012 | 251 | 0.040 |
Why?
| | Mice, Nude | 1 | 2012 | 680 | 0.040 |
Why?
| | Organ Size | 1 | 2012 | 461 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2012 | 4151 | 0.040 |
Why?
| | Vascular Patency | 1 | 2020 | 121 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2012 | 276 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 408 | 0.040 |
Why?
| | Antitubercular Agents | 1 | 2012 | 208 | 0.040 |
Why?
| | Down-Regulation | 1 | 2012 | 618 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 508 | 0.040 |
Why?
| | Syndrome | 1 | 2011 | 381 | 0.040 |
Why?
| | Cerebrovascular Circulation | 1 | 2022 | 290 | 0.040 |
Why?
| | Cattle | 1 | 2012 | 946 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2012 | 441 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 936 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2024 | 779 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2012 | 1300 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2012 | 340 | 0.040 |
Why?
| | A549 Cells | 1 | 2019 | 75 | 0.040 |
Why?
| | Postoperative Care | 1 | 2011 | 286 | 0.040 |
Why?
| | Anesthesia | 1 | 2012 | 257 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1475 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1050 | 0.030 |
Why?
| | Survivors | 1 | 2022 | 523 | 0.030 |
Why?
| | Pilot Projects | 1 | 2024 | 1898 | 0.030 |
Why?
| | Stents | 1 | 2022 | 564 | 0.030 |
Why?
| | Risk | 1 | 2020 | 923 | 0.030 |
Why?
| | Burnout, Professional | 1 | 2024 | 488 | 0.030 |
Why?
| | STAT3 Transcription Factor | 1 | 2019 | 206 | 0.030 |
Why?
| | Biomarkers | 2 | 2012 | 4302 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1547 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2012 | 1450 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2022 | 924 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1662 | 0.030 |
Why?
| | Lung Diseases | 1 | 2012 | 782 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2012 | 3634 | 0.030 |
Why?
| | Prognosis | 1 | 2012 | 4330 | 0.020 |
Why?
| | Age Factors | 1 | 2020 | 3346 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 920 | 0.020 |
Why?
| | Osteopontin | 1 | 2012 | 35 | 0.020 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 45 | 0.020 |
Why?
| | Insulin | 1 | 2023 | 2516 | 0.020 |
Why?
| | Pravastatin | 1 | 2011 | 45 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2447 | 0.020 |
Why?
| | Hypertension | 1 | 2020 | 1276 | 0.020 |
Why?
| | Heptanoic Acids | 1 | 2011 | 67 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 206 | 0.020 |
Why?
| | Simvastatin | 1 | 2011 | 59 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 887 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 440 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 6033 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2011 | 2770 | 0.020 |
Why?
| | Pyrroles | 1 | 2011 | 220 | 0.020 |
Why?
| | Adolescent | 2 | 2023 | 22577 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 848 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1217 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2011 | 1165 | 0.020 |
Why?
| | Infant | 1 | 2012 | 10091 | 0.020 |
Why?
| | Child, Preschool | 1 | 2012 | 11868 | 0.020 |
Why?
| | Suicide | 1 | 2014 | 729 | 0.020 |
Why?
| | Phenotype | 1 | 2012 | 3170 | 0.010 |
Why?
| | Child | 1 | 2012 | 22740 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 14254 | 0.010 |
Why?
|
|
Rove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|